Images List Premium Download Classic

Breast Cancer

Breast Cancer-related patent applications - as published by the U.S. Patent and Trademark Office (USPTO).


loading
Quinoline derivative
September 13, 2018 - N°20180258072

A compound represented by general formula (i) has a strong axl inhibitory activity by introducing a distinctive bicyclic structure in which a saturated carbon ring is fused to a pyridone ring, and can be a therapeutic agent for axl-related diseases, for example, cancer such as acute myeloid leukemia, melanoma, breast cancer, pancreatic cancer, and glioma, kidney diseases, immune system diseases, ...
Lipofullerene-saccharide conjugates and their use as antimetastatic agents for the inhibition of mammalian neoplasms
September 13, 2018 - N°20180256728

In some embodiments, a lipofullerene-saccharide compound and a method of inhibiting and/or ameliorating metastasis of neoplastic cells using said compound is disclosed herein. The lipofullerene-saccharide compound may be used in therapeutically effective doses to inhibit the metastasis of neoplasms in mammals.
Breast ultrasound scanning
September 13, 2018 - N°20180256130

A method and apparatus for acquisition of volumetric breast images for screening and/or diagnosing breast cancers using a rotary scanning template and transducer.. .
Breast Cancer Patent Pack
Download 198+ patent application PDFs
Breast Cancer Patent Applications
Download 198+ Breast Cancer-related PDFs
For professional research & prior art discovery
inventor
  • 198+ full patent PDF documents of Breast Cancer-related inventions.
  • Exact USPTO filing data with full-text, images, drawings & claims.
  • Index pages: Table View and Image-Grid View layouts. All images in each PDF.
Antibody drug conjugates (adc) that bind to 158p1d7 proteins
Seattle Genetics, Inc.
September 06, 2018 - N°20180251566

Antibody drug conjugates (adc's) that bind to 158p1d7 protein and variants thereof are described herein. 158p1d7 exhibits tissue specific expression in normal adult tissue, and is aberrantly expressed in glioblastoma, lung cancer, bladder cancer, and breast cancer.
Methods of treating her2-positive cancer
Genentech, Inc.
September 06, 2018 - N°20180251557

Methods of treating patients having her2-positive cancer are provided. Certain methods involve treatment of her2 positive breast cancer using a programmed cell death protein 1 (pd-1) binding antagonist or a programmed death ligand 1 (pd-l1) binding antagonist in combination with trastuzumab and pertuzumab or with trastuzumab emtansine.
Histone demethylase inhibitors
Celgene Quanticel Research, Inc.
September 06, 2018 - N°20180251458

The present disclosure relates generally to compositions and methods for treating cancer and neoplastic disease. Provided herein are substituted pyridine derivative compounds and pharmaceutical compositions comprising said compounds.
Breast Cancer Patent Pack
Download 198+ patent application PDFs
Breast Cancer Patent Applications
Download 198+ Breast Cancer-related PDFs
For professional research & prior art discovery
inventor
  • 198+ full patent PDF documents of Breast Cancer-related inventions.
  • Exact USPTO filing data with full-text, images, drawings & claims.
  • Index pages: Table View and Image-Grid View layouts. All images in each PDF.
Co-therapy comprising a small molecule csf-1r inhibitor and an agonistic antibody that specifically binds ...
Janssen Biotech, Inc.
September 06, 2018 - N°20180250398

The present invention is directed to methods for treating cancer, preferably a solid tumor or hematological malignancy, including for example pancreatic cancer, lung cancer (including but not limited to non-small cell lung cancer (nsclc)), prostate cancer, colorectal cancer, breast cancer, melanoma or non-hodgkin's lymphoma, comprising administering to a subject in need thereof a therapeutically effective amount of co-therapy comprising, consisting ...
Adjuvant treatment of her2-positive breast cancer
F. Hoffmann-la Roche Ag
September 06, 2018 - N°20180250397

Methods are provided for the adjuvant treatment of operable her2-positive primary breast cancer in human patients by administration of pertuzumab in addition to chemotherapy and trastuzumab. The methods reduce the risk of recurrence of invasive breast cancer or death for a patient diagnosed with her2-positive early breast cancer (ebc) compared to administration of trastuzumab and chemotherapy, without pertuzumab..
System and method for computing survivorship risk associated with delaying therapy in breast cancer
International Business Machines Corporation
August 23, 2018 - N°20180240550

An estimate is made of a time since a given presenting cancer would have first been detectable using a known diagnostic technique, and an estimate is also made of initial characteristics of the given presenting cancer at the time when it would have first been detectable using the known diagnostic technique. A first probability of the cancer being present in ...
System and method for computing survivorship risk associated with delaying therapy in breast cancer
International Business Machines Corporation
August 23, 2018 - N°20180239875

An estimate is made of a time since a given presenting cancer would have first been detectable using a known diagnostic technique, and an estimate is also made of initial characteristics of the given presenting cancer at the time when it would have first been detectable using the known diagnostic technique. A first probability of the cancer being present in ...
Free ngal as a biomarker for cancer
Children's Medical Center Corporation
August 23, 2018 - N°20180238896

Uncomplexed neutrophil gelatinase associated lipocalin (ngal) is present at increased levels in individuals with atypical ductal hyperplasia (adh), a major risk factor for future breast cancer development; in individuals that have ovarian cancer; and in individuals that have breast cancer, both invasive and noninvasive. Accordingly, the present invention is directed to measuring uncomplexed ngal levels in urine as a primary ...
Method of diagnosing, treating and determining progression and survival of cancer cells using bcl-2 antagonist ...
H. Lee Moffitt Cancer Center And Research Institute, Inc.
August 23, 2018 - N°20180238892

The present invention relates to the bad pathway's influence on development, progression, chemo-sensitivity, and overall survival for multiple human cancers and its potential as a therapeutic target to increase chemo-sensitivity. Bad pathway expression was associated with the development and/or progression of breast, colon, and endometrial cancers, relapse-free survival from breast cancer, and overall survival from ovarian, colon, and brain ...
Methylation biomarkers for breast cancer
King Abdullah University Of Science And Technology
August 23, 2018 - N°20180237867

Different combinations of methylation status based biomarkers can be used to test for breast cancer with high sensitivity and high specificity.. .
Breast Cancer Patent Pack
Download 198+ patent application PDFs
Breast Cancer Patent Applications
Download 198+ Breast Cancer-related PDFs
For professional research & prior art discovery
inventor
  • 198+ full patent PDF documents of Breast Cancer-related inventions.
  • Exact USPTO filing data with full-text, images, drawings & claims.
  • Index pages: Table View and Image-Grid View layouts. All images in each PDF.
Herceptin® adjuvant therapy
Genentech, Inc.
August 23, 2018 - N°20180236093

The present application describes adjuvant therapy of nonmetastatic breast cancer using herceptin®.. .
Compositions and methods for cancer expressing pde3a or slfn12
Bayer Pharma Ag
August 23, 2018 - N°20180235961

The present invention features improved methods of identifying patients having cancer (e.g., melanoma, adenocarcinoma, lung, cervical, liver or breast cancer) using biomarkers (e.g., pde3a, slfn12) that correlate with drug sensitivity and consequently treating a stratified patient population with an agent of the invention (e.g., dnmdp, zardaverine, and anagrelide).. .
Use of ceranib-2 in the treatment of lung cancer and breast cancer
Anadolu Universitesi Rektorlugu
August 23, 2018 - N°20180235951

The present invention relates to the use of ceranib-2 molecule in the treatment of lung cancer and breast cancer. At the same time, the present invention also describes the in vitro studies made by the inventors in this direction..
Cancer treatment methods
University Of Notre Dame Du Lac
August 23, 2018 - N°20180235936

Methods for treating cancer include administering and/or receiving, at a patient in need thereof, a therapeutic dose of an inhibitor of extracellular vesicle signaling. The methods can additionally include co-administering and/or additionally receiving, at the patient in need thereof, a therapeutic dose or regimen of chemotherapy.
Unimolecular nanoparticles for efficient delivery of therapeutic cationic peptides
Wisconsin Alumni Research Foundation
August 23, 2018 - N°20180235897

Provided herein are peptides comprising an amino acid sequence having at least about 85% sequence identity to ryrprapiiavt (seq id no: 1). These cationic peptides inhibit pkm2 methylation and may be used in the treatment of breast cancer and other diseases or conditions in which pkm2 is overexpressed.
Methods of diagnosing and treating cancer
UniversitÉ Paul Sabatier Toulouse Iii
August 16, 2018 - N°20180231556

The present invention relates to methods for the diagnosis and the treatment of cancer, in particular breast cancer. In particular, the present invention relates to a method of diagnosing cancer in a subject comprising the steps of i) determining the expression level of 11βhsd1 and/or 11βhsd2 in a sample obtained from the subject, ii) comparing ...
Personalized tumor biomarkers
The Johns Hopkins University
August 16, 2018 - N°20180230550

Clinical management of human cancer is dependent on the accurate monitoring of residual and recurrent tumors. We have developed a method, called personalized analysis of rearranged ends (pare), which can identify translocations in solid tumors.
Gene expression markers for breast cancer prognosis
Genomic Health, Inc.
August 16, 2018 - N°20180230548

The present invention provides gene sets the expression of which is important in the diagnosis and/or prognosis of breast cancer.. .
Loading